{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:19:33Z","timestamp":1791227973740,"version":"4.1.0"},"reference-count":18,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,2,7]],"date-time":"2007-02-07T00:00:00Z","timestamp":1170806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Small Animal Practice"],"published-print":{"date-parts":[[2007,5]]},"abstract":"<jats:p><jats:bold>O<jats:sc>bjectives<\/jats:sc>:<\/jats:bold><jats:bold>The clinical efficacy and safety of imidapril were evaluated in dogs that presented with mild to severe congestive heart failure (New York Heart Association stage II to IV) by comparing the success rate of imidapril with a positive control by a non\u2010inferiority approach.<\/jats:bold><\/jats:p><jats:p><jats:bold>M<jats:sc>ethods<\/jats:sc>:<\/jats:bold><jats:bold>This good, clinical practice compliant, multicentre study (EFFIC study) enrolled 142 client\u2010owned dogs and was conducted in 20 locations in France, Belgium and Germany. Dogs of various breed, age and weight were included in the study. These dogs were randomised into two groups that were treated for 84 days with either the test product, imidapril, or the positive control, benazepril, and followed up in parallel over this period. Both treatments were administered at a dose of 0\u00b725 mg\/kg once a day with the possibility of doubling this dose to 0\u00b75 mg\/kg if considered necessary from a clinical point of view. In addition, concomitant treatment was given to dogs presenting with pulmonary oedema and\/or ascites, supraventricular tachyarrhythmia and\/or dilated cardiomyopathy. The evolution of the New York Heart Association stage and the \u201cfunctional signs\u201d score were evaluated as primary efficacy criteria.<\/jats:bold><\/jats:p><jats:p><jats:bold>R<jats:sc>esults<\/jats:sc>:<\/jats:bold><jats:bold>The success rate in the imidapril group was 66 compared with 68 per cent in the benazepril group. Regarding safety, 35 dogs in each group experienced at least one adverse event. Nine dogs in each group experienced at least one serious adverse event. The difference between these results was not statistically significant.<\/jats:bold><\/jats:p><jats:p><jats:bold>C<jats:sc>linical<\/jats:sc>S<jats:sc>ignificance<\/jats:sc>:<\/jats:bold><jats:bold>Imidapril is as efficacious and safe as the reference product, benazepril.<\/jats:bold><\/jats:p>","DOI":"10.1111\/j.1748-5827.2006.00170.x","type":"journal-article","created":{"date-parts":[[2007,2,7]],"date-time":"2007-02-07T23:51:59Z","timestamp":1170892319000},"page":"265-270","source":"Crossref","is-referenced-by-count":10,"title":["Clinical evaluation of imidapril in congestive heart failure in dogs: results of the EFFIC study"],"prefix":"10.1111","volume":"48","author":[{"given":"B.","family":"Besche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Chetboul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.\u2010P.","family":"Lachaud Lefay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Grandemange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,2,7]]},"reference":[{"key":"e_1_2_6_2_1","unstructured":"Amberger C. A. Bernay\u2010Stazzu F. Rougier S. Borell D. Davot J. L. Woehrle F.&Boisram\u00e9 B. (2003)Efficacy and tolerance of imidapril compared to enalapril in dog with naturally acquired heart failure (\u201cFIRST\u201d study). Proceedings of the 21st Annual ACVIM forum. June 4 to 7 Charlotte NC USA. p 967"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1760-2734(06)70025-X"},{"key":"e_1_2_6_4_1","doi-asserted-by":"crossref","unstructured":"CONSENSUS Trial Study Group(1987)Effect of enalapril on mortality in severe congestive heart failure.New England Journal of Medicine316 1429\u20101435","DOI":"10.1056\/NEJM198706043162301"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1995.tb01075.x"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780030302"},{"key":"e_1_2_6_7_1","unstructured":"EMEA(2001)Guideline on Statistical Principles for Veterinary Clinical Trials. EMEA\/CVMP\/816\/00 \u2013 FINAL.European Agency for the Evaluation of Medicinal Products London UK"},{"key":"e_1_2_6_8_1","unstructured":"EMEA\/CPMP(1999)Points to Consider on Biostatistical\/Methodological Issues Arising from Recent CPMP Discussions on Licensing Applications: Superiority Non\u2010Inferiority and Equivalence. Draft CPMP\/EWP\/182\/99.European Agency for the Evaluation of Medicinal Products London UK"},{"key":"e_1_2_6_9_1","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2460\/javma.1998.213.11.1573","article-title":"Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long\u2010Term Investigation of Veterinary Enalapril (LIVE) Study Group","volume":"213","author":"Ettinger S. J.","year":"1998","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(81)90233-7"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1995.tb01074.x"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1292\/jvms.59.513"},{"key":"e_1_2_6_13_1","first-page":"844","volume-title":"Textbook of Veterinary Internal Medicine","author":"Knight D","year":"1995"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0034-5288(95)90055-1"},{"key":"e_1_2_6_15_1","first-page":"289","article-title":"Therapie des herzinsuffizienten Hundes mittels Benazepril\u2010HCL (Fortekor): Ergebnisse einer Langzeitstudie: Klinischer Verlauf und elektrokardiographische Kontrolle","volume":"86","author":"Kolm U.","year":"1999","journal-title":"Wien Tier\u00e4rztl Mschr"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1995.tb01092.x"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198325010-00002"},{"key":"e_1_2_6_18_1","first-page":"725","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions","volume":"327","author":"SOLVD Investigators","year":"1992","journal-title":"New England Journal of Medicine"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.2307\/2532800"}],"container-title":["Journal of Small Animal Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1748-5827.2006.00170.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1748-5827.2006.00170.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T20:49:04Z","timestamp":1707598144000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1748-5827.2006.00170.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,7]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["10.1111\/j.1748-5827.2006.00170.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1748-5827.2006.00170.x","archive":["Portico"],"relation":{},"ISSN":["0022-4510","1748-5827"],"issn-type":[{"value":"0022-4510","type":"print"},{"value":"1748-5827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,7]]}}}